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INTRODUCTION
Prostate cancer is the most common cancer diagnosed in men and is the second leading cause of cancer-related death among men in the United States (Jemal et al., 2005) . American Cancer Society statistics project 232,090 new prostate cancer cases for 2005, and that 30,350 patients will die this year. It is therefore imperative to find new therapies for coping with this major health problem. Anti-angiogenic therapy offers an attractive option for the treatment, since tumor progression depends on angiogenesis.
Microvascular wall is composed of two cell types; endothelium and pericyte. The functional role of pericytes in angiogenesis and their potential as anti-angiogenic targets in prostate cancer have only recently drawn attention of investigators. Overall aim of our research supported by DAMD 17-03-1-0012 is to establish pericyte and NG2 proteoglycan located on pericyte as novel anti-angiogenic target for treatment of prostate cancer. This overall aim is organized into 3 sub-divisions (tasks) for experimental testing:
1) Analysis of neovasculature in prostate cancer.
2) Demonstrate the feasibility of pericyte-based targeting by investigating the ability of NG2-neutralizing antibody to inhibit angiogenesis in LNCaP and PC-3 prostate cancers grown in nude mouse cornea. 3) Analysis of transgenic adenocarcinoma of mouse prostate (TRAMP) grown in NG2 knockout and wildtype mice to elucidate the effect of intrinsic (genetic) targeting of NG2 proteoglycan on pericytes.
PROGRESS OF THE RESEARCH IN THE LAST 12 MONTHS IN THE LIGHT OF THE STATEMENT OF WORK
Task 1. Mapping the pericyte/endothelial cell relationship in prostate tumors Task IA was accomplished and reported already in last year's progress report. Task lB. Analysis of vasculature in prostate tumors: Vasculature in LNCaP and PC-3 tumor tissues along with TRAMP tissues were analyzed in more detail. We encountered lymphatic vessels in addition to blood vessels in prostate tumor tissues and therefore expanded the analysis of neovasculature to include lymphangiogenic vessels in Task 3. Immunohistochemical and confocal microscopic analysis of PC-3 and LNCaP, and TRAMP tumors revealed the following findings: 1) NG2+ and PDGF receptor-p3+ pericytes invest the endothelium in neovasculature extensively in all three types of prostate tumors studied. 2) All three types of tumors have extensive lymphangiogenic vessels expressing LYVE-1. Since we encountered extensive lymphangiogenesis in Task IB, we wish to analyze not only blood vessel microvascular density but lymphatic vessel density in Task 3 in TRAMP tumors grown in NG2 knockout and wild type mice. The cornea is a thin (400 microns), transparent, avascular tissue in which the growth of all new angiogenic vessels generated in response to implanting tumor xenografts can be quantified in a straightforward manner using a stereomicroscope (Kenyon et al., 1997) . In a modification of four established in vivo techniques (Muthukkaruppan and Auerbach, 1979) (Kenyon et al., 1997 ) (Fernandez et al., 2001 ) (Ozerdem, 2005) , pellets containing anti-NG2 antibody were tested for their ability to inhibit corneal angiogenesis induced by PC-3 or LNCAP tumor fragments. These tests were performed to reveal the extent to which NG2 blockage can slow the angiogenesis that occurs in response to prostate tumors implanted in sixweek-old, male, outbred athymic mice (Crl:nu/nu) (Charles River Laboratories, Wilmington, MA).
The surgical procedures for inducing corneal angiogenesis in the mouse (Muthukkaruppan and Auerbach, 1979) (Kenyon et al., 1996) (Kenyon et al., 1997) (Fernandez et al., 2001 ) are modified to accommodate tumor xenografts and hydron pellets containing either rabbit anti-NG2, or isotype-matched non-immune globulin (control) by making a wider keratotomy incision and a deeper micropocket. Male nude athymic mice (Crl:nu/nu) were obtained from Charles River Laboratories, (Wilmington, MA). Male nude mice (Crl:nu/nu) were obtained from Charles River Laboratories, (Wilmington, MA). and used for inducing PC-3 and LNCAP prostate tumor xenografts.
Hydron pellets (0.4x0.4x0.2 mm) containing the NG2 antibody or control nonimmune globulin, and tumor fragment (0.3x0.3x0.3 mm) were implanted in the corneal pocket in male nude mice (Crl:nu/nu). Tumor fragments were prepared from subcutaneous PC-3 or LNCAP prostate tumor xenografts grown in nude mice (total 4 donor mice). Slow-release polyhydroxyethyl methacrylate (hydron) (Hydro Med Sciences, Cranbury, NJ) pellets are formulated to contain 45jg sucrose aluminum sulfate (sucralfate) (Sigma, St.Louis, MO) plus one of two experimental additives: 0.8jg affinity-purified rabbit anti-NG2 antibody (Ozerdem, 2005) (Ozerdem and Stallcup, 2004 ) (Ozerdem and Stallcup, 2003) , or 0.8 gg isotype-matched non-immune globulin. Six-week-old mice were anesthetized with Avertin (0.015-0.017 ml/g body weight), and under an operating microscope, one pellet and tumor fragment were surgically implanted into the corneal stroma of one eye at a distance of 0.7 mm from the corneo-scleral limbus. Corneal stromal micropockets were created by using a modified von Graefe knife. Treatment pellet and matching control pellet eyes received the tumor fragment from the same donor. Twenty (20) eyes were operated for PC 3 tumor implantation. Ten (10) eyes were operated for LNCAP tumor implantation. On postoperative day 7, angiogenesis was quantified by determining the area of vascularization by using Olympus Stereoscope SZX 12 (Olympus USA, Melville, NY) as described previously (Kenyon et al., 1997) . Hydron pellets containing NG2 neutralizing antibody decreased corneal neovascularization induced by PC3 or LNCaP fragments xenografted in the cornea. (Figure 1. and 2) PC3 xenograft in nude mouse cornea 3.5- .,.
--Treatment Control p= 0.0079 Figure 2 . Hydron pellets containing NG2 neutralizing antibody decreased corneal neovascularization induced by LNCaP tumor xenografts significantly. Mean corneal neovascularization in the treated eyes and control eyes were 0.3393 mm 2 , and 3.443 mm2 respectively (n=10 eyes, p=0.0079 Mann Whitney U test). (Grako et al., 1999) (Ozerdem and Stallcup, 2004) were generated via a conventional homologous recombination approach (Mansour et al., 1988) (Capecchi, 1989) . The mice were back-crossed onto a C57BL/6 genetic background and NG2+/-heterozygotes were mated to establish separate male NG2 knockout (NG2-/-) and wild type (NG2+/+) colonies. NG2 knockout mouse has shown decreased neovascularization in cornea and retina challenged with angiogenic growth factors and ischemia in a previous study when challenged with angiogenic growth factors and ischemia respectively (Ozerdem and Stallcup, 2004) . TRAMP (Transgenic Adenocarcinoma of Mouse Prostate) (Greenberg et al., 1995) C57BL/6-TgN (TRAMP) 8247Ng mouse breeders were obtained from the National Cancer Institute, Mouse Models of Human Cancers Consortium (MMHCC catalog number 01XC6 Frederick, MD). For genotyping, genomic DNA from tail was isolated, and the transgene was identified by PCR as described previously (Greenberg et al., 1995) . The mice had been back-crossed at least 10 generations onto the C57BL/6 background at the time of these experiments. TRAMP prostate tumor fragments and cell lines have previously been verified to be transplantable and tumorigenic when implanted in mouse with C57BL/6 genetic background (Foster et (Ozerdem and Stallcup, 2003) . Four, male TRAMP mice (24 week old) carrying transgene served as donor for tumor implantation in 6-week-old male NG2 knockout and wild type mice. Four NG2 knockout and 4 wild type control mice were used as recipients. Following a 3-mm skin incision in the dorsum, a 2mm x 2mmx 2mm fragment of tumor is implanted subcutaneosuly and the skin incision is closed with LiquiVet tissue adhesive (American Health Service, Libertyville, IL). The mice were followed for 3 weeks and sacrificed for tumor retrieval. Seven NG2 knockout and 7 wild type control mice were used for TRAMP-Cl cell line inoculation. TRAMP-Cl cells (5x 106 cells) were injected subcutaneously in the dorsum. The mice were followed for 3 weeks and sacrificed for tumor retrieval.
Immunohistochemistry, Confocal Microscopic Imaging, and Image Analysis
Tissues were fixed in 4% paraformaldehyde for 6 hours, cryoprotected in 20% sucrose overnight, and frozen in O.C.T. embedding compound (Miles, Inc., Elkhardt, IN). Cryostat sections (40 gam) were air-dried onto Superfrost slides (Fisher Scientific, Pittsburgh, PA).
Blood vessel endothelial cells (BEC) were identified using a cocktail of rat antibodies against mouse endoglin (CD 105), PECAM-1 (CD3 1), and VEGF receptor-2 (flk-1) (Pharmingen, San Diego, CA) (Chang et Following cryosectioning, 5 sections representing the entire thickness of the tumor tissue were selected from the numbered sections by using systematic random sampling (Dawson and Trapp, 2001 ). The sampled histological sections (220 sections from TRAMP and TRAMP-Cl grafts) were imaged with a multi-channel laser scanning confocal microscope for microvascular density(MVD) and lymphatic vascular density (LVD). Briefly, optical sections were obtained from the specimens using the Fluoview 1000 laser scanning confocal microscope (Olympus USA, Melville, NY) in the threechannel sequential scanning mode. Serial optical sections (1 gim each) across the entire thickness (40 jgm) of the histological specimens were overlaid (Z-stack) to provide reconstructions of entire vessels. This allowed unambiguous identification of the spatial relationship between pericytes and endothelial cells in the vessel wall.
The Volocity image analysis software (Openlab-Improvision Inc, Lexington MA) (serial # 88262001) will be used for quantification of MVD, and LVD in prostate tumors grown in NG2 knockout and wild type mice. The Classifier Module will be set Volocity to automatically identify MVD or LVD following multi-channel scanning to accomplish Task 3B in upcoming months.
KEY RESEARCH ACCOMPLISHMENTS
> Our results arising from finished Task 2-related experiments suggest that as early players in angiogenesis pericytes and NG2 proteoglycan represent an additional target for treatment of prostate cancer. Neovascular pericytes in prostate cancer can thus be targeted extrinsically (pharmacologically) by using hydron pellets loaded with NG2 neutralizing antibodies to inhibit neovascularization. Introduction reliable identification of pericytes have been elusive [5, 7, 8] . As a result, the benefits of using pericytes as an Angiogenesis is an essential element of many pathological additional target for anti-angiogenic therapy are just beginprocesses, including tumor growth and metastasis, psoriasis, ning to be explored [9, 10] . acne rosacea, rheumatoid arthritis, proliferative diabetic
The effectiveness of using pericytes as anti-angiogenic retinopathy, retinopathy of prematurity, and age-related targets would be expected to depend heavily on the macular degeneration [1, [2] [3] [4] . The development of anti-importance of these cells in the development and function angiogenic therapies for treating these pathologies has of microvessels: i.e. the more important their function, the therefore become an increasingly important goal of bio-greater the impact of targeting them. The functional medical research. Most of these strategies have focused on importance of pericytes during angiogenesis is vividly targeting endothelial cells, which form the inner lining of illustrated by the phenotypes of mice in which pericyte the vascular tube and are by far the best understood development is disrupted. Ablation of PDGF-B or PDGF component of neovasculature. However, the walls of typical fl-receptor, critical elements for the recruitment and develangiogenic microvessels have a second cellular component: opment of pericytes, gives rise to mice that are pericytenamely, pericytes (mural cells) which form an outer sheath deficient. Depending on the timing and specificity of the around the endothelium [2, 5, 6] . Much less is known about ablations, microvessels in these animals, at the very least, these perivascular cells, as evidenced by the 115-fold have dramatically altered morphologies [11, 12] and in difference in the number of publications on endothelial cells some cases are subject to lethal microaneurysms [13] . and pericytes, respectively (revealed by a recent search of Despite their importance, PDGF #-receptor and PDGF-B do the PUBMED database). The origin, function, and even not necessarily represent the only effective means of targeting pericytes. During the process of angiogenesis, . eyeballs and retinas. Serial sections were cut through the The NG2 proteoglycan binds with high affinity to basic entire thickness of the eyes, yielding between 85 and 132 fibroblast growth factor (bFGF), platelet-derived growth sections per pair of eyes. Despite this range in the number of factor AA (PDGF-AA), and the kringle domains of sections obtained, the variation was random, with no plasminogen and angiostatin [21, 22] . In addition, NG2 statistical difference between the number of sections derived appears to mediate signal transduction events that lead to from wild type or knockout eyes (P=0.0952, Mannincreased cell spreading and motility [23] [24] [25] [26] [27] . This combi-Whitney test). The total number of cryosections obtained nation of properties, coupled with the high level of NG2 from each group of mice was 1104. expression on nascent microvascular pericytes during Using systematic random sampling [32] , we selected five developmental angiogenesis [19] , has led us to investigate sections per mouse to provide a representative sampling of the functional role of the proteoglycan in neovasculariza-both retinas. The sections were stained using the perition. Towards this end, we have utilized well-characterized odic acid-Schiff (PAS) method, with hematoxylin counterretinal and corneal models to compare the details of staining as described [31] . This allowed the identification of pathological angiogenesis in wild type and NG2 null mice. the so-called neovascular tufts, or clusters of pathological We have previously demonstrated that NG2 expression is angiogenic vessels protruding beyond the internal limiting restricted to microvascular pericytes, rather than endothelial membrane of the retina into the vitreous. Quantification of cells, in pathological ocular angiogenesis [18] and tumor pathological angiogenesis was accomplished by counting angiogenesis [17] . The genetic ablation of NG2 can the number of vascular cell nuclei in these tufts. We therefore be regarded as a specific "intrinsic" targeting of compiled the data according to the number of angiogenic pericytes in pathological microvasculature. We have also nuclei per section (with each section representing a pair of used anti-NG2 antibodies for "extrinsic" targeting of eyes). We processed five sections per mouse, and therefore pericyte-expressed NG2. Both types of studies demonstrate compared 25 wild type sections with 25 knockout sections. the functional importance of NG2 during pathological
In a separate experiment, mice received daily intraperineovascularization, establishing the potential value of the toneal injections of BrdU (80 ug/g body weight) on proteoglycan as a pericyte-specific target for anti-angiogenic postnatal days 14 through 18 after withdrawal from therapy.
hyperoxia. This allowed subsequent identification of mitotic cells in the pathological vascular tufts present in the P18 retinas. Right and left eyes from each mouse (one wild type Materials and methods and one NG2 null mouse) were frozen in pairs into OCT blocks and sectioned. Two sets of right and left pairs were Experimental animals mounted on each slide. Systematic random sampling was then used to select five slides for each animal. Thus, each NG2 null mice [28] were generated via a conventional animal was represented by 20 sections (10 left eyes and 10 homologous recombination approach [29, 30] . The mice right eyes). Slides were immunostained for PDGF fiwere back-crossed onto a C57B1/6 genetic background for receptor and BrdU and counter-stained with hematoxylin. six generations, and NG2+/-heterozygotes were mated to The percentages of mitotic pericytes and endothelial cells establish separate NG2 knockout (NG2-/-) and wild type were determined after quantifying the number of BrdU-(NG2+/+) colonies, positive nuclei in each of the two immunohistochemicallydefined cell types.
Animal models
Dual hydron pellet corneal angiogenesis All animal studies were performed in accordance with National Institutes of Health Office of Laboratory Animal The surgical procedure for inducing corneal angiogenesis in Welfare (OLAW) guidelines, and were approved by the the mouse [33] was modified for this study to incorporate authors' institutional animal research committees.
two pellets in the corneal pocket instead of just a single pellet. Slow-release polyhydroxyethyl methacrylate (hyIschemia-induced retinal angiogenesis dron) (Hydro Med Sciences, Cranbury, New Jersey) pellets Ischemic retinal angiogenesis was induced by withdrawal of (0.4 x 0.4 X 0.2 mm) were formulated to contain 45 jg neonatal mice from hyperoxia [31] . Litters of postnatal day sucrose aluminum sulfate (sucralfate) (Sigma, St. Louis, 7 (P7) NG2 knockout and wild type mice were placed along Missouri) plus one of three experimental additives: 90 ng with their nursing dams in an environmentally controlled recombinant bFGF (Life Technologies, Carlsbad, Califorchamber (75% oxygen-25% nitrogen atmosphere) for nia), 0.8 jg affinity-purified rabbit anti-NG2 antibody [17-5 days. At P12, the animals were returned to room air, 19], or PBS (control). Ten-week-old mice were anesthetized and at P17 the mice were sacrificed and the eyes enucleated. with Avertin (0.015-0.017 ml/g body weight), and under an In total, five mice of each genotype were utilized, allowing operating microscope two pellets were surgically implanted Targeting pericytes in neovascularization 271 into the comeal stroma of one eye at a distance of 0.7 mm Results from the comeo-scleral limbus. Ten NG2 wild-type mice received pairs of pellets containing bFGF and NG2 Ischemic angiogenesis is diminished in the NG2 null retina antibody. Another 10 NG2 wild type mice received pairs (intrinsic targeting) of pellets containing bFGF and PBS. Thirteen NG2 knockout mice received pairs of pellets containing bFGF The stereotyped laminar architecture of the retina makes it and PBS. Over an 8 day-period after recovery from surgery, an ideal tissue for quantification of ischemic neovascularthe mice were examined under a Leica GZ6 stereomicro-ization [4, 31] . In the hyperoxia model, the return from scope (Leica, Allendale, New Jersey) to evaluate the exposure to 75% oxygen to a normal atmosphere represents progress of corneal angiogenesis in the operated eyes. On relative hypoxia, resulting in the sprouting of new blood day 8, angiogenesis was quantified by determining the area vessels from the primary vascular plexus at the inner face of of vascularization, as described previously [33, 34] . the retina. Many of these new vessels protrude into the vitreous, where they are easily recognized as pathological Tissue processing, immunohistochemistry, and imaging angiogenic tufts composed of endothelial cells positive for endoglin (CD 105), PECAM-I (CD3 1), and VEGF receptorTissues were fixed in 4% paraformaldehyde for 6 h, 2 (flk-1) and pericytes positive for PDGF /3-receptor. In the cryoprotected in 20% sucrose overnight, and frozen in wild type mouse retina, the profusion of abnormal vascular OCT embedding compound (Miles, Inc., Elkhardt, Indiana). protrusions beyond the inner limiting retinal membrane is Cryostat sections (40 um) were air-dried onto Superfrost readily apparent (outlined area in Figure lb) . By contrast, slides (Fisher Scientific, Pittsburgh, Pennsylvania). Immu-relatively few ectopic vessels are present in the NG2 null nohistochemical labeling was carried out as previously retina after parallel hypoxic induction (Figure la) . The described [17] [18] [19] . Pericytes were identified by labeling enlargement and morphological distortion of the hypoxic with affinity-purified rabbit polyclonal antibodies against wild type retina are reproducible phenomena caused by the NG2 proteoglycan or the PDGF fl-receptor [13, [17] [18] [19] , edema due to leakage of fluid from the extensive patholog-35]. Both NG2 and PDGF /3-receptor are regarded as ical neovasculature. Edema is not apparent in the hypoxic specific markers for pericytes [36, 37 ]. An affinity-purified NG2 null retina, presumably due to the relative scarcity of rabbit antibody against the alpha subunit of hypoxia-pathological vessels. inducible factor-1 (HIFlc) was a generous gift from Dr. Robert Abraham (The Burnham Institute, La Jolla, California).
(
a) (b)
Since endothelial cells express different cell surface markers as a function of developmental age [38] , we ,.
identified them using a cocktail of antibodies against endoglin (CD105), PECAM-1 (CD31), and VEGF receptor-2 (flk-1) (Pharmingen, San Diego, California). This strategy has been previously utilized to maximize labeling of all vascular endothelial cells, both immature and mature wild type (b) retinas from the ischemia protocol were examined at P17 after tion in 5% goat serum in PBS for 30 min [43] prior to PAS/hematoxylin staining. In the wild type retina there is a profusion of incubation with antibody. Fluorescence microscopic imag-vascular tufts protruding past the internal limiting membrane into the ing of endothelial (CD31 + CD105 + flkl) [38, 39] , vitreous (area enclosed by dashed line). These ectopic vessels are much less pericyte (NG2 or PDGF /3-receptor) [13, 18, 19] , and common in the NG2 null retina (arrow indicating neovasculature). The wild nuclear (BrdU) markers [43] was performed according to type retina is also characterized by swelling and distortion from edema the published methods. with BrdU in the ischemic wild type retina vs. 18.7 % of to provide endothelial cell data. In the wild type retina 38.3% of endothelial pericytes in the knockout retina (statistically significant, cells are BrdU-positive (WT-EC), compared to 22.8% in the NG2 null P = 0.0068 Mann-Whitney test). Counting BrdU-positive retina (KO-EC) (P=0.0147). (b) The data used to construct (a) were also nuclei in PDGF fl-receptor-negative cells also allowed us to used to determine the pericyte/endothelial cell investment ratio in ischemic vascular tufts (total number of pericyte nuclei/total number of endothelial compare mitotic indices for endothelial cells. Interestingly, cell nuclei). For wild type retinas this ratio was almost one pericyte per 38.3% of endothelial cells are BrdU-positive in the wild endothelial cell (0.86), while in NG2 null retinas the ratio fell to 0.24 type retina, vs. 22.8% in the NG2 null retina (P---0.0147 (P= 0.0011). The high ratio ofpericytes to endothelial cells in the wild type Mann-Whitney test).
retina is characteristic of microvasculature in the central nervous system. The validity of these results was confirmed in a separate set of experiments in which BrdU-positive nuclei were counted in conjunction with staining with the endothelial knockout neovasculature. Determination of the respective antibody cocktail to identify endothelial cells. The mitotic numbers of pericyte and endothelial cell nuclei associated indices for both endothelial cells and pericytes were reduced with the angiogenic tufts allows us to determine the pericyte in NG2 null retinas. Both types of labeling paradigms to endothelial cell investment ratio in these clusters of (endothelial cocktail and PDGF fl-receptor) therefore dem-vessels (Figure 2b) . In wild type neovasculature the P/E onstrate a reduction in proliferation of pericytes and investment ratio is 0.86 (i.e. close to one pericyte per endothelial cells in the NG2 null retina. Reduced prolifer-endothelial cell), while in the knockout retina the P/E value ation of these cell populations is likely to be an important falls to 0.24 (only one pericyte for every four endothelial factor in the sub-normal angiogenic response of the NG2 cells) (P= 0.0011 Mann-Whitney test). The observation null retina to hypoxia. that pericyte proliferation is more adversely affected than We have previously demonstrated in wild type mice that endothelial cell proliferation in knockout retinas may the extensive investment of ischemic retinal vessels by partially account for this difference in P/E investment ratios. NG2-positive, PDGF fl-receptor-positive pericytes is comIt has been shown that an early step in the angiogenic parable to the high pericyte:endothelial cell (P/E) ratio response of the retinal vasculature to withdrawal from normally seen in the central nervous system [18, 19 ]. An hyperoxia is up-regulation of the HIF-1 transcription factor. additional important distinction between pathological ves-HIF-1 plays a critical role in the induction of VEGF sels in the wild type and NG2 null retinas is the relative expression and subsequent steps in the angiogenic process scarcity of pericytes relative to endothelial cells in the [44] . Immunostaining for the HIF-lca subunit was used to evaluate this initial response of wild type and NG2 null wild type mice vs. knockout mice, and 0.0039 for control retinas to hypoxia. Very low HIF-1 Ic levels were observed in wild type mice vs. antibody treated wild type mice). Thus control retinas from P13 wild type and knockout mice. In both intrinsic (genetic ablation) and extrinsic (antibody contrast, 16 h after removal of experimental P13 pups from blocking) targeting of NG2 result in diminished comeal 75% oxygen, HIF-la was up-regulated in similar fashion in angiogenesis. the inner layers of both the wild type and NG2 null retinas (data not shown). Differences in pathological retinal neovascularization between the two genotypes therefore are not Discussion due to the initial response of retinal cells to hypoxia, but to subsequent neovascularization events downstream of HIF-Since the cellular processes underlying neovascular sprout Icc expression.
formation remain incompletely understood [45, 46] , increased attention to pericytes and their interaction with Corneal angiogenesis is reduced by both intrinsic and endothelial cells will be required not only to attain a better extrinsic targeting of NG2 understanding of neovascularization in general, but also to realize the full potential of anti-angiogenic therapy. The Implantation of a bFGF-containing pellet along with a critical contribution of pericytes during angiogenesis has control PBS-containing pellet induces a robust angiogenic been well established by observation of the pathological response in the wild type mouse cornea (Figure 3a) . We phenotypes of mice in which pericyte development is have shown that these comeal microvessels are richly blocked [11, 13, 47] . The functional importance of pericytes invested by NG2-positive, PDGF fl-receptor-positive peri-has been attributed largely to their ability to stabilize and cytes [18] . If the second pellet contains anti-NG2 provide structural support to pre-existing endothelial tubes. antibody instead of PBS, the angiogenic response to They are thought to accomplish this by controlling endobFGF is substantially reduced (Figure 3b) . A diminished thelial cell proliferation and motility, and by contributing to response to bFGF is also observed in the NG2 null the establishment of a permeability barrier and the regulacornea (Figure 3c ). These qualitative observations were tion of blood flow [36, [48] [49] [50] [51] [52] [53] . However, it is now quantified by measuring the extent of the vascularized becoming clear that pericytes can play a much earlier role areas in each of the three experimental situations (Fig-in microvascular development than previously realized. The ure 3d). The mean area of corneal neovascularization was use of NG2 and other markers for nascent pericytes has 0.3863 mm 2 in the control group of wild type mice revealed the participation of these cells in the earliest stages (n = 10), compared with 0.087 mm 2 in the NG2 knockout of angiogenesis [6, 36, [16] [17] [18] [19] [20] [53] [54] [55] [56] . Pericytes may even animals (n = 13). In the presence of an NG2 antibody-be important for the stimulation and guidance of nascent containing pellet, corneal vascularization in wild type vascular tubes. Strategies for targeting pericytes may mice was reduced to 0.1445 mm 2 (n= 10). Both of these therefore be able to affect not only existing vessels, but differences were statistically significant (P=0.0006 for also the formation of new vessels. Our current studies show that intrinsic targeting of NG2 neutralize the growth-inhibitory effects of angiostatin [22, (by genetic ablation) leads to decreased ischemic angiogen-57] may promote endothelial cell proliferation in the wild esis in the mouse retina in response to hypoxia. The wild type mouse, an effect that would be absent in the NG2 null type mouse retina contains more than twice as many mouse. pathological vascular tufts as the retina of the NG2 null
In addition to the quantitative reduction of ischemic mouse. Since HIF-Ic• induction is similar in wild type and angiogenesis in the NG2 knockout mouse, capillaries in the knockout retinas, we know that the defect in the null mouse null mouse also have an altered cellular composition. The lies not in the initial response of retinal cells to hypoxia, but pericyte:endothelial cell investment ratio in ischemic vessels probably in later stages of vascular cell responsiveness to of the wild type retina is 0.86, or almost one pericyte per HIF-l-induced factors such as VEGF. This seems reason-endothelial cell. This high investment ratio is characteristic able in light of the fact that NG2 is not expressed by cells of of capillaries in the central nervous system in general, and the retina per se, but instead by pericytes in the microvas-the retina in particular, possibly contributing to the integrity culature [17] [18] [19] .
of the blood-brain barrier and the high metabolic needs of A major factor in the sub-normal angiogenic response of neural tissues [5, 36] . This investment ratio falls to 0.24 in the NG2 null retina appears to be reduced vascular cell the ischemic neovasculature of the NG2 null retina. The proliferation. Only 41% as many mitotic pericytes are relative changes in pericyte and endothelial cell proliferation present in the ischemic vasculature of the NG2 null retina as in the NG2 knockout mouse would not appear to account for in the wild type retina. These data represent the first direct in the magnitude of this decrease. Thus other factors that we vivo evidence in support of a role for NG2 in cell have not yet investigated, such as decreased cell motility or proliferation. The ability of NG2 to sequester growth factors increased apoptosis, may contribute to the large decrease in such as bFGF and PDGF-AA and possibly assist in pericyte number relative to that of endothelial cells. While a presentation of these factors to their respective signaling specific role for NG2 in apoptosis has not been explored, receptors could represent one mechanism by which the there are numerous indications of NG2 involvement in proteoglycan promotes cell proliferation [21, 28] .
cytoskeletal reorganization and cell motility [23] [24] [25] [26] [27] [28] . In Interestingly, the absence of NG2 and the decreased future work it will therefore be important for us to number of mitotic pericytes is accompanied by a 1.7-fold investigate the impact of NG2 on these processes in the decrease in the number of mitotic endothelial cells, sugges-context of neovascularization. tive of a stimulatory effect of pericytes on endothelial cell Intrinsic targeting of NG2 by genetic ablation leads to an proliferation. This idea is somewhat at odds with previous even more pronounced decrease in bFGF-induced comreal reports that pericytes can inhibit endothelial cell prolifera-angiogenesis. Neovasculature covers a 4.4-fold greater tion in cell culture models [48] and that the absence of surface area in the wild type cornea than in the NG2 null pericytes is accompanied by endothelial cell hyperplasia cornea, once again supporting the idea that NG2 plays a role in vivo [11] . However, the pericyte/endothelial cell relation-in pericyte development and/or function, and in the develship is a complex, dynamic one that is likely to vary opment of new vasculature. Interestingly, extrinsic targeting depending on the specific model under investigation. An of NG2 through the use of a neutralizing antibody also excellent example of this is provided by a recent study of the produces a significant decrease in comeal angiogenesis (2.7-proliferative retinopathy that results from endothelial cell-fold). While our data do not allow us to determine which specific ablation of PDGF-B [47] . The general conclusion aspects of pericyte function are blocked by the antibody, from this work was that reduction of pericyte density below previous studies have shown that anti-NG2 antibodies are 50% of normal, invariably led to the development of capable of blocking growth factor-induced cell proliferation proliferative retinopathy. Nevertheless, localized instances [58] and both growth factor-induced and extracellular were also encountered in the same investigation [47] in matrix-induced cell motility [27, 59] in cell culture models. which increased pericyte density promoted the formation of Our demonstration of the functional importance of NG2 chaotic, endothelial cell-rich vasculature, demonstrating that during pathological ocular angiogenesis logically raises the under certain conditions pericytes can have pro-angiogenic question of the proteoglycan's function during normal properties. The ability to use pericytes as effective anti-developmental neovascularization. How can we rationalize angiogenic targets also is suggestive of the pro-angiogenic the observation that the NG2 knockout mouse possesses nature of these cells [9, 10] .
functional vasculature? More than one answer is possible. Our current data support a pro-angiogenic role for First, pathological angiogenesis may differ in some respects pericytes in the formation of ischemic retinal microvessels. from normal angiogenesis. During pathological angiogeneOur results with wild type mice show that endothelial sis, the vasculature may be responding to combinations of cells are richly invested by NG2-positive, PDGF /f-signals that are not normally experienced during developreceptor-positive pericytes in this pathological vasculature ment or else are occurring out of their normal sequence (see also [18] ). Coupled with our documentation of the early (multiple factors released by tumor cells would be a good participation of NG2-positive pericytes during neovascular-example). The role of NG2 may be magnified under these ization [17] , these observations suggest the possibility that abnormal circumstances. Additional experiments with wild pericyte-derived factors or NG2-dependent sequestration of type and NG2 knockout mice are planned in order to growth factors might act to promote the proliferation of examine NG2-dependent aspects of angiogenesis in other endothelial cells. Alternatively, the ability of NG2 to types of pathological models such as tumor progression and 
